Healthcare -
Biotechnology - NASDAQ - US
$ 2.4
-6.98 %
$ 167 M
Market Cap
-0.46
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Phathom Pharmaceuticals, Inc.
| Revenue | 55.3 M |
| Cost Of Revenue | 7.97 M |
| Gross Profit | 47.3 M |
| Operating Expenses | 325 M |
| Operating Income | -277 M |
| Other Expenses | 56.9 M |
| Net Income | -334 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 55.3 | 0.7 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 8.0 | 0.2 | 0.6 | 0.5 | 0.3 | 8 K | 0 |
| Gross Profit | 47.3 | 0.5 | (0.6) | (0.5) | (0.3) | 8 K | 0 |
| OPERATING INCOME | |||||||
| Operating Expenses | 324.7 | 167.8 | 172.4 | 135.1 | 125.7 | 106.2 | 1.2 |
| Selling, General and Administrative Expenses | 290.7 | 117.9 | 101.0 | 62.7 | 27.5 | 6.9 | 1.2 |
| Research and Development Expenses | 34.1 | 49.9 | 71.4 | 72.3 | 98.1 | 99.3 | 20 K |
| Operating Income | (277.5) | (167.3) | (172.4) | (135.1) | (125.7) | (106.2) | (1.2) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | 72.0 | 42.0 | 27.3 | 6.8 | 4.6 | 4.2 | 13 K |
| Total Other Income | (56.9) | (34.3) | (25.3) | (8.8) | (3.4) | (148.9) | 63 K |
| Pre-Tax Income | (334.3) | (201.6) | (197.7) | (143.9) | (129.1) | (255.1) | (1.3) |
| NET INCOME | |||||||
| Tax Provision | 0 | 0 | 25.3 | 4.2 | 4.2 | (45.4) | 13 K |
| Net Income | (334.3) | (201.6) | (223.0) | (148.1) | (133.3) | (209.7) | (1.3) |
| EPS | 5.29 | 3.93 | 5.7 | 4 | 4.01 | 8.48 | 0.15 |